EE04467B1 - 1S-[1alfa(2S*,3R*),9alfa]-6,10-diokso-N-(2-etoksü-5-oksotetrahüdro-3-furanüül)-9-[[( 1-isokinolüül)karbonüül]amino]oktahüdro-6H-püridasino[1,2-a][1,2]diasepiin-1-karboksamii di veevaba ja hüdraatunudkristalliline vorm, nende valmistamismeetod, kasut - Google Patents
1S-[1alfa(2S*,3R*),9alfa]-6,10-diokso-N-(2-etoksü-5-oksotetrahüdro-3-furanüül)-9-[[( 1-isokinolüül)karbonüül]amino]oktahüdro-6H-püridasino[1,2-a][1,2]diasepiin-1-karboksamii di veevaba ja hüdraatunudkristalliline vorm, nende valmistamismeetod, kasutInfo
- Publication number
- EE04467B1 EE04467B1 EEP200000586A EEP200000586A EE04467B1 EE 04467 B1 EE04467 B1 EE 04467B1 EE P200000586 A EEP200000586 A EE P200000586A EE P200000586 A EEP200000586 A EE P200000586A EE 04467 B1 EE04467 B1 EE 04467B1
- Authority
- EE
- Estonia
- Prior art keywords
- 9alpha
- pyridazino
- oxotetrahydro
- 1alpha
- diazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9804367A FR2777279B1 (fr) | 1998-04-08 | 1998-04-08 | Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide |
| PCT/FR1999/000799 WO1999052935A1 (fr) | 1998-04-08 | 1999-04-07 | Formes cristallines du 1s-[1alpha (2s*,3r*),9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepine-1- carboxamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200000586A EE200000586A (et) | 2002-02-15 |
| EE04467B1 true EE04467B1 (et) | 2005-04-15 |
Family
ID=9524993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000586A EE04467B1 (et) | 1998-04-08 | 1999-04-07 | 1S-[1alfa(2S*,3R*),9alfa]-6,10-diokso-N-(2-etoksü-5-oksotetrahüdro-3-furanüül)-9-[[( 1-isokinolüül)karbonüül]amino]oktahüdro-6H-püridasino[1,2-a][1,2]diasepiin-1-karboksamii di veevaba ja hüdraatunudkristalliline vorm, nende valmistamismeetod, kasut |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US6544977B1 (ko) |
| EP (1) | EP1070083B1 (ko) |
| JP (1) | JP2002511485A (ko) |
| KR (1) | KR100582981B1 (ko) |
| CN (1) | CN1202123C (ko) |
| AP (1) | AP1734A (ko) |
| AR (1) | AR018328A1 (ko) |
| AT (1) | ATE315044T1 (ko) |
| AU (1) | AU758042B2 (ko) |
| BG (1) | BG64736B1 (ko) |
| BR (1) | BR9909549A (ko) |
| CA (1) | CA2325629C (ko) |
| CU (1) | CU23055A3 (ko) |
| CZ (1) | CZ299744B6 (ko) |
| DE (1) | DE69929315T2 (ko) |
| DK (1) | DK1070083T3 (ko) |
| EA (1) | EA002761B1 (ko) |
| EE (1) | EE04467B1 (ko) |
| ES (1) | ES2253880T3 (ko) |
| FR (1) | FR2777279B1 (ko) |
| GE (1) | GEP20032974B (ko) |
| HK (1) | HK1038575B (ko) |
| HR (1) | HRP20000665B1 (ko) |
| HU (1) | HU227561B1 (ko) |
| ID (1) | ID26290A (ko) |
| IL (2) | IL138818A (ko) |
| ME (1) | ME01627B (ko) |
| NO (1) | NO327995B1 (ko) |
| NZ (1) | NZ507199A (ko) |
| PL (1) | PL197016B1 (ko) |
| RS (1) | RS49916B (ko) |
| SI (1) | SI1070083T1 (ko) |
| SK (1) | SK286267B6 (ko) |
| TR (1) | TR200002914T2 (ko) |
| TW (1) | TW522152B (ko) |
| UA (1) | UA71563C2 (ko) |
| WO (1) | WO1999052935A1 (ko) |
| ZA (1) | ZA200005438B (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101479245B (zh) * | 2006-06-30 | 2013-05-22 | 诺瓦提斯公司 | 喹啉酮衍生物和其药物组合物 |
| AU2014277867B2 (en) * | 2007-12-04 | 2016-11-03 | Arbutus Biopharma Corporation | Targeting lipids |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5552400A (en) * | 1994-06-08 | 1996-09-03 | Sterling Winthrop Inc. | Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
-
1998
- 1998-04-08 FR FR9804367A patent/FR2777279B1/fr not_active Expired - Lifetime
-
1999
- 1999-03-15 TW TW088103966A patent/TW522152B/zh not_active IP Right Cessation
- 1999-03-30 AR ARP990101432A patent/AR018328A1/es active IP Right Grant
- 1999-04-07 ES ES99911890T patent/ES2253880T3/es not_active Expired - Lifetime
- 1999-04-07 CA CA2325629A patent/CA2325629C/fr not_active Expired - Fee Related
- 1999-04-07 US US09/647,858 patent/US6544977B1/en not_active Expired - Lifetime
- 1999-04-07 HU HU0101586A patent/HU227561B1/hu not_active IP Right Cessation
- 1999-04-07 BR BR9909549-1A patent/BR9909549A/pt not_active Application Discontinuation
- 1999-04-07 RS YUP-608/00A patent/RS49916B/sr unknown
- 1999-04-07 AT AT99911890T patent/ATE315044T1/de active
- 1999-04-07 ID IDW20002015A patent/ID26290A/id unknown
- 1999-04-07 DE DE69929315T patent/DE69929315T2/de not_active Expired - Lifetime
- 1999-04-07 NZ NZ507199A patent/NZ507199A/xx not_active IP Right Cessation
- 1999-04-07 SI SI9930877T patent/SI1070083T1/sl unknown
- 1999-04-07 SK SK1488-2000A patent/SK286267B6/sk not_active IP Right Cessation
- 1999-04-07 TR TR2000/02914T patent/TR200002914T2/xx unknown
- 1999-04-07 CU CU20000213A patent/CU23055A3/es unknown
- 1999-04-07 AU AU30416/99A patent/AU758042B2/en not_active Ceased
- 1999-04-07 GE GEAP19995614A patent/GEP20032974B/en unknown
- 1999-04-07 AP APAP/P/2000/001939A patent/AP1734A/en active
- 1999-04-07 WO PCT/FR1999/000799 patent/WO1999052935A1/fr active IP Right Grant
- 1999-04-07 DK DK99911890T patent/DK1070083T3/da active
- 1999-04-07 CN CNB998071455A patent/CN1202123C/zh not_active Expired - Fee Related
- 1999-04-07 ME MEP-2000-608A patent/ME01627B/me unknown
- 1999-04-07 CZ CZ20003678A patent/CZ299744B6/cs not_active IP Right Cessation
- 1999-04-07 PL PL343350A patent/PL197016B1/pl unknown
- 1999-04-07 KR KR1020007011159A patent/KR100582981B1/ko not_active IP Right Cessation
- 1999-04-07 EA EA200001047A patent/EA002761B1/ru not_active IP Right Cessation
- 1999-04-07 EP EP99911890A patent/EP1070083B1/fr not_active Expired - Lifetime
- 1999-04-07 JP JP2000543491A patent/JP2002511485A/ja active Pending
- 1999-04-07 EE EEP200000586A patent/EE04467B1/xx unknown
- 1999-07-04 UA UA2000116295A patent/UA71563C2/uk unknown
-
2000
- 2000-10-02 IL IL138818A patent/IL138818A/en not_active IP Right Cessation
- 2000-10-05 ZA ZA200005438A patent/ZA200005438B/en unknown
- 2000-10-06 BG BG104829A patent/BG64736B1/bg unknown
- 2000-10-06 NO NO20005060A patent/NO327995B1/no not_active IP Right Cessation
- 2000-10-09 HR HR20000665A patent/HRP20000665B1/xx not_active IP Right Cessation
-
2002
- 2002-01-07 HK HK02100107.8A patent/HK1038575B/zh not_active IP Right Cessation
- 2002-11-18 US US10/299,242 patent/US6946459B2/en not_active Expired - Lifetime
-
2005
- 2005-04-14 IL IL168047A patent/IL168047A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
| ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
| HUP0100950A3 (en) | Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUT51254A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUP0002404A3 (en) | Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use | |
| HUP0000664A3 (en) | Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions | |
| HUP0202624A3 (en) | Pyrazolo[4,3-d]pyrimidine-derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| BR9507771A (pt) | Processos para preparação de ácido 1-Butil-2-(2'-(2H-Tetratozol-5-IL)-Bifenil-4-Ilmetil(-1H-Indol-3-Carboxílico | |
| HUP0105054A3 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation | |
| IL123900A0 (en) | New phenylamidine derivatives processes for preparing them and their use as pharmaceutical compositions | |
| AP9400676A0 (en) | Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-1h-indole-5-ethanesulphonamid-e and physiologically acceptable salts thereof | |
| ITMI940989A0 (it) | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione | |
| EE04467B1 (et) | 1S-[1alfa(2S*,3R*),9alfa]-6,10-diokso-N-(2-etoksü-5-oksotetrahüdro-3-furanüül)-9-[[( 1-isokinolüül)karbonüül]amino]oktahüdro-6H-püridasino[1,2-a][1,2]diasepiin-1-karboksamii di veevaba ja hüdraatunudkristalliline vorm, nende valmistamismeetod, kasut | |
| ITMI951417A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
| AP2000001973A0 (en) | Novel octahydro-6,10-dioxo-6h-pyridazino/1,2-a/1,2/diazepine-1-carboxylic acid derivatives preparation method and use for preparing therapeutically active compounds | |
| HRP940315A2 (en) | Process for the preparation of pharmaceutical compositions containinbg active ingredient | |
| AU6843498A (en) | Process for the preparation of n-(3-hydroxy-succinyl)-amino acid derivatives | |
| IT1296495B1 (it) | Impiego di bisfosfonati nella preparazione di forme farmaceutiche per somministrazione intramuscolare | |
| HUP0001402A3 (en) | 6,7-disubstituted-4-aminopyrido[2,3-d] pyrimidine compounds, pharmaceutical compositions thereof and process for their preparation | |
| HUT53121A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| IT9021240A0 (it) | Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche | |
| ITMI952711A1 (it) | Esteri amminoacidici di amminoetanoli, procedimento per la loro preparazione, loro impiego come agenti antifertilita' e relative composizioni farmaceutiche | |
| ITMI940374A1 (it) | Derivati di acidi ammino-solfonici, loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione | |
| ITMI930076A1 (it) | Procedimento per la preparazione di timopentina 5 (tp5) in fase solida | |
| SI0888286T1 (en) | Novel substituted cyclic amino acids as pharmaceutical agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB1A | Change in the ownership or in the address of the owner | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |